Rapport Therapeutics Inc

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$27.08

-0.38 (-1.38%)

As of Mar 22, 10:09 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 15 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +66.8% upside

Low Target $32.24

Average Target $45.18

High Target $61.72

Current Price $27.08

Current
$27.08

Target
$45.18

$32.24 $45.18 avg $61.72

Scenario Analysis

Bear Case

$32.24

19.1%

Low target

Base Case

$45.18

+66.8%

Avg target

Bull Case

$61.72

+127.9%

High target

Risk/Reward

6.7x

Highly favorable

Price in Context

52-Week High

$42.27

-35.9% from high

52-Week Low

$7.40

+265.9% from low

Target vs 52W High

$45.18

+6.9% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+45.2%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+24.8%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+33.4%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+24.3%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+196.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+79.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-22.9%
VTRS Viatris Inc	Buy	18	67%	$122.82	+809.8%